Annual Operating Expenses
$103.64 M
+$4.56 M+4.60%
December 31, 2024
Summary
- As of March 13, 2025, YMAB annual total operating expenses is $103.64 million, with the most recent change of +$4.56 million (+4.60%) on December 31, 2024.
- During the last 3 years, YMAB annual operating expenses has fallen by -$44.18 million (-29.89%).
- YMAB annual operating expenses is now -32.05% below its all-time high of $152.51 million, reached on December 31, 2022.
Performance
YMAB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$24.59 M
-$192.00 K-0.77%
December 31, 2024
Summary
- As of March 13, 2025, YMAB quarterly total operating expenses is $24.59 million, with the most recent change of -$192.00 thousand (-0.77%) on December 31, 2024.
- Over the past year, YMAB quarterly operating expenses has dropped by -$192.00 thousand (-0.77%).
- YMAB quarterly operating expenses is now -50.33% below its all-time high of $49.50 million, reached on June 30, 2022.
Performance
YMAB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
YMAB Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.6% | -0.8% |
| 3 y3 years | -29.9% | -19.6% |
| 5 y5 years | +24.9% | -19.6% |
YMAB Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.0% | +4.6% | -50.3% | +5.4% |
| 5 y | 5-year | -32.0% | +24.9% | -50.3% | +5.4% |
| alltime | all time | -32.0% | +508.2% | -50.3% | +540.0% |
Y-mAbs Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $103.64 M(+4.6%) | $24.59 M(-0.8%) |
| Sep 2024 | - | $24.78 M(-16.2%) |
| Jun 2024 | - | $29.57 M(+19.8%) |
| Mar 2024 | - | $24.69 M(+0.7%) |
| Dec 2023 | $99.08 M(-35.0%) | $24.52 M(-4.0%) |
| Sep 2023 | - | $25.56 M(+9.6%) |
| Jun 2023 | - | $23.32 M(-9.1%) |
| Mar 2023 | - | $25.67 M(-16.1%) |
| Dec 2022 | $152.51 M(+3.2%) | $30.58 M(-15.2%) |
| Sep 2022 | - | $36.08 M(-27.1%) |
| Jun 2022 | - | $49.50 M(+36.2%) |
| Mar 2022 | - | $36.35 M(-17.2%) |
| Dec 2021 | $147.82 M | $43.90 M(+18.3%) |
| Sep 2021 | - | $37.12 M(+11.6%) |
| Jun 2021 | - | $33.25 M(-0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $33.55 M(-13.2%) |
| Dec 2020 | $138.48 M(+66.8%) | $38.64 M(+18.4%) |
| Sep 2020 | - | $32.64 M(-19.3%) |
| Jun 2020 | - | $40.45 M(+51.2%) |
| Mar 2020 | - | $26.75 M(+12.6%) |
| Dec 2019 | $83.00 M(+92.0%) | $23.76 M(-2.5%) |
| Sep 2019 | - | $24.36 M(+30.7%) |
| Jun 2019 | - | $18.63 M(+14.6%) |
| Mar 2019 | - | $16.25 M(+15.4%) |
| Dec 2018 | $43.23 M(+124.6%) | $14.08 M(+23.3%) |
| Sep 2018 | - | $11.41 M(+11.3%) |
| Jun 2018 | - | $10.26 M(+37.2%) |
| Mar 2018 | - | $7.48 M(-19.4%) |
| Dec 2017 | $19.24 M(+12.9%) | $9.28 M(+141.4%) |
| Sep 2017 | - | $3.84 M |
| Dec 2016 | $17.04 M | - |
FAQ
- What is Y-mAbs Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual operating expenses year-on-year change?
- What is Y-mAbs Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly operating expenses year-on-year change?
What is Y-mAbs Therapeutics annual total operating expenses?
The current annual operating expenses of YMAB is $103.64 M
What is the all time high annual operating expenses for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual total operating expenses is $152.51 M
What is Y-mAbs Therapeutics annual operating expenses year-on-year change?
Over the past year, YMAB annual total operating expenses has changed by +$4.56 M (+4.60%)
What is Y-mAbs Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of YMAB is $24.59 M
What is the all time high quarterly operating expenses for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly total operating expenses is $49.50 M
What is Y-mAbs Therapeutics quarterly operating expenses year-on-year change?
Over the past year, YMAB quarterly total operating expenses has changed by -$192.00 K (-0.77%)